SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase...
Hence then, the article about co diagnostics announces 3 0 million private placement priced at the market under nasdaq rules was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules )
Also on site :
- SBVA Appoints Two Global Investment Veterans as Venture Partners to Strengthen Portfolio Growth Support
- Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts
- Bringing Digital Characters to Life: Tencent Games Motus Makes Gamescom Debut with End-to-End AI Animation Pipeline